ARMER THOMAS A 4
4 · MAP Pharmaceuticals, Inc. · Filed Jan 25, 2013
Insider Transaction Report
Form 4
ARMER THOMAS A
DirectorCSO, Director
Transactions
- Sale
Common Stock
2013-01-23$24.76/sh−59,620$1,476,191→ 129,162 total - Exercise/Conversion
Common Stock
2013-01-23$6.39/sh+39,620$253,160→ 188,782 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-01-23−39,620→ 0 totalExercise: $6.39Exp: 2017-05-01→ Common Stock (39,620 underlying)
Footnotes (2)
- [F1]The transaction was made pursuant to a 10b5-1 trading plan in effect at the time of the transaction.
- [F2]Fully exercisable.